Scandinavian Multicenter Study to Advance Risk Stratification in Heart Disease- Ventricular Arrhythmias

NCT02864771 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 504

Last updated 2020-06-04

No results posted yet for this study

Summary

The purpose of this study is to identify markers of increased risk for incident ventricular arrhythmias and cardiovascular events in patients already being treated with an implantable cardioverter-defibrillator (ICD) by exploring patient history and clinical findings, biological markers, ECG markers, and echocardiographic markers.

Conditions

  • Ventricular Arrhythmias
  • Implantable Defibrillator User
  • Biological Markers
  • Heart Disease

Sponsors & Collaborators

  • Helse Stavanger HF

    collaborator OTHER_GOV
  • University of Oslo

    collaborator OTHER
  • University Hospital, Akershus

    lead OTHER

Principal Investigators

  • Torbjørn Omland, MD,PhD, MPH · Professor of Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2019-12-31
Completion
2050-12-31

Countries

  • Norway

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02864771 on ClinicalTrials.gov